Molecular Diagnostics Technique Capturing Significant Attention Among Reference Laboratories, Hospitals, and Blood Banks owing to its Ability to Early Disease Diagnosis | Abbott, bioMérieux, Danaher Corporation, Qiagen, and Roche

According to the latest study published by AnalystView Market Insights, by the end of 2025, global molecular diagnostics market is expected to reach USD 11.9 billion with the CAGR of 9.1%.

In vitro diagnostics and in vivo imaging techniques are the two primary areas of disease diagnosis. Molecular diagnostics helps in the early detection of cancer, genetic disorders, and other infectious diseases. It asses an individual’s health at the molecular level and aids in the detection and measurement of specific genetic sequences in deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) or the proteins expressed by them. Genetic test methods such as in situ hybridization or genome sequencing identify the gene expression patterns whereas protein detection test such as mass a spectrometry help to identify protein expression patterns. Genes are the functional units of DNA that produce RNA through the process of transcription. This, in turn, regulates the production of proteins which make up the machinery of cells.

The techniques employed by molecular diagnostics help uncover the variation of genes and proteins in a cell and focus on their activity patterns to diagnose and monitor diseases, detect risk and asses which therapy will be best suited for individual patients. These tests also help to detect and quantify the presence of bacteria, viruses or types of cells. For example, molecular diagnostics can help a doctor to decide which drug is best suited for the treatment of a late-stage melanoma patient. It can be used to monitor the level of HIV virus in a patient’s blood or to understand the likelihood of reoccurrence of breast cancer in a female patient.

Get access to exclusive PDF brochure of this study @
www.analystviewmarketinsights.com/request_sample/av150/

Key Takeaways:
- Acceptance of molecular diagnostic tests, for the detection and treatment of cancer, is rapidly increasing. With the help of molecular diagnostics, the expression patterns of cancerous cells can be analyzed effectively, thus physicians can decide the best therapy for the patient
- Technology advancement is an important driving factor for the market growth. Advancements have improved the accuracy of test results, thus there has been a widespread use of molecular diagnostics in small scale and large scale healthcare facilities
- It is estimated that molecular diagnostics devices are projected to migrate into cheaper handheld devices for greater use at point of care and other healthcare facilities
- Reagent segment captured the largest share of the total market owing to the development of new reagents for various diagnostic testing assays
- Infectious disease segment is the largest market and is projected to grow significantly over the future period. Growth is primarily due to the emergence of novel technologies for the detection of infectious diseases
- North America accounted for the largest share owing to the rising research and development activities coupled with new product approvals
- The industry is consolidated in nature. Competition among key players is widespread throughout the world. Companies such as Abbott, Danaher Corporation, bioMérieux, Qiagen, and Roche influence industry significantly.

Click here to obtain more highlight on “Molecular Diagnostics Market, By Products, By Location, By Application and Geography– Analysis, Share, Trends, Size, & Forecast From 2014 – 2025” study @
www.analystviewmarketinsights.com/report-highlight-molecular-diagnostics-market-150/

Global Molecular Diagnostics Market: Snapshot

Molecular Diagnostics Market, by Products
- Instruments
- Reagent

Molecular Diagnostics Market, by Location
- Point of care
- Self-test
- Central Laboratories

Molecular Diagnostics Market, by Application
- Infectious Diseases
- Blood Screening
- Histology
- Oncology
- Prenatal
- Pharmacogenomics
- Coagulation
- Tissue Typing
- Inherited Diseases

Market, by Region
North America (U.S. and Canada), Europe (France and Germany), Asia Pacific (India and China), Middle East and Africa, Latin America and Rest of the World

Key players profiled in this report with special attention on competitive landscape includes, (can be further customized to include additional 10 profiles of companies):
- Abbott Laboratories
- Danaher Corporation
- BioMérieux
- Qiagen
- Roche Diagnostics

USP of our key vendor analysis:
1. Well-designed strategic framework design for these key players will help to understand the market movement including regional expansion, mergers & acquisitions, and new product developments
2. Thorough SWOT i.e. Strength, Weakness, Opportunities and Threat for individual company profiling is analyzed in order to present a detailed market opportunity assessment.

Key benefits of the report:
• The report presents a macro and micro-level outlook regarding the industry. Thus, it becomes easy for our clients to perceive the business landscape and take a glimpse of their own standing in it.
• A thorough analysis of relevant statistical data to estimate the market paradigms
• Exceptional understanding of region and country-specific markets. The report will answer some of the toughest questions regarding the market shares, sizes, forecasts segmentations, and growth specific to the countries.
• Well-designed strategic framework analyzes the market movements including regional expansion, mergers & acquisitions, and new product developments

Research Methodology:
- Preliminary Data Mining: Secondary Research, Paid Databases, Primary Research
- Data Synthesis & Analysis: Top-Down Approach, Bottom-Up Approach, Supply Side and Demand Side
- Market Formulation: Market Dynamics, Total Addressable Market and Machine Learning Technique
- Data Verification: Quality Assurance and Reach a Conclusion

To enquire more about our research process and report store, please connect @
https://www.analystviewmarketinsights.com/get-in-touch/

About Us
AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends for various industries such as Healthcare, Bulk Chemicals, Semiconductors, Electronics, and Foods and Beverages.

Contact Us
Mr. Jose (Press & Marketing Manager)
Corporate Sales, USA
AnalystView Market Insights
Email: sales@analystviewmarketinsights.com
Tel: +91-757-498-5725 (Asia-Pacific Business Centre)
Web: www.analystviewmarketinsights.com

This release was published on openPR.